COMMUNIQUÉS West-GlobeNewswire

Terveystalo Plc: Terveystalo sells the entire share capital of Porin Linnankulma Mutual Real Estate Company
16/04/2018
Terveystalo Plc Stock Exchange Release 16 April 2018 at 14.30 EET Suomen Terveystalo Oy has entered into an agreement with the eQ Hoivakiinteistö Mutual Fund on 16 April 2018, with which Terveystalo sells the entire [...]
Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting
16/04/2018
CG’806 targets multiple pathways and kills cancer cells resistant to other FLT3 and BTK inhibitors CHICAGO and SAN DIEGO and TORONTO, April 16, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO ) (TSX: APS [...]
Veritas Pharma Enters Into Share Purchase Agreement with 3 Carbon Extractions Inc.
16/04/2018
3 Carbon is in the business of designing cannabis extraction facilities and utilizing its own proprietary extraction methods. VANCOUVER, British Columbia, April 16, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT [...]
OHSU and Aptose Present New CG’806 Preclinical Data at 2018 AACR Annual Meeting
16/04/2018
CG’806 Continues to Demonstrate Superior Activity to Other FLT3 and BTK Inhibitors Against Patient Samples CHICAGO and PORTLAND, Ore. and SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Oregon Health & Science [...]
Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance
16/04/2018
RUTHERFORD, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced that it has [...]
Detroit Tigers seventh annual Pink Out the Park Sunday, May 13, brings Fans and Community Together to Raise Awareness of Breast Health
16/04/2018
Celebrate Mother’s Day by paying tribute to moms and honoring breast cancer survivors. DETROIT, April 16, 2018 (GLOBE NEWSWIRE) -- The Detroit Tigers will present the seventh annual Pink Out the Park on Mother’s Day, [...]
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City
16/04/2018
Geneva, Switzerland and Boston, MA - April 16, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions [...]
Stemline Therapeutics Expands Board of Directors; Further Enhances Commercial Expertise with Appointment of Darren Cline
16/04/2018
NEW YORK, April 16, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced expansion of its Board of [...]
Recro Pharma to Present IV Meloxicam Data at the 43rd Annual Regional Anesthesiology and Acute Pain Medicine Meeting
16/04/2018
MALVERN, Pa., April 16, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today [...]
Celldex’s METRIC Study in Metastatic Triple-negative Breast Cancer Does Not Meet Primary Endpoint
16/04/2018
Conference Call Scheduled for 8:00 a.m. ET Today HAMPTON, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX ) today reported that the Company’s randomized, Phase 2b METRIC Study of [...]
Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting
16/04/2018
Durable Mcl-1 suppression of at least 24 hours after a single dose of CYC065 BERKELEY HEIGHTS, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) (NASDAQ: CYCCP ) ("Cyclacel" or the [...]
Zynerba Pharmaceuticals Appoints John P. Butler to Board of Directors
16/04/2018
DEVON, Pa., April 16, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE ), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative [...]
Apricus Biosciences Announces Outcome of Vitaros™ End-of-Review Meeting with FDA
16/04/2018
FDA Confirms Vitaros Regulatory Pathway Company Seeking Partner to Develop Vitaros in U.S. Company Evaluating Strategic Alternatives SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI [...]
Humanigen Signs Agreement With MD Anderson Cancer Center to Begin Research Investigating Lenzilumab as CAR-T Support
16/04/2018
BRISBANE, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- Humanigen, Inc. (OTCQB:HGEN), a biopharmaceutical company pursuing cutting-edge science to develop its proprietary monoclonal antibodies for immunotherapy and [...]
Nova Leap Health Corp. Completes Purchase of Second Massachusetts Home Care Business and Reaches $9 Million Annualized Recurring Revenue
16/04/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, April 16, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV:NLH) ("Nova Leap" or “the Company”), a [...]
Idera Pharmaceuticals Enters into a Clinical Development Support Agreement with Pillar Partners Foundation to Expand the Clinical Research on IMO-2125 beyond PD-1 Refractory Melanoma
16/04/2018
Pillar Partners to provide funding for up to three Investigator Initiated Clinical Trials EXTON, Pa., April 16, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera”) (NASDAQ: IDRA ), a clinical-stage [...]
BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Relapsed or Refractory Mature T-and NK-Cell Lymphomas
16/04/2018
CAMBRIDGE, Mass. and BEIJING, China, April 16, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
IRADIMED CORPORATION to Hold 2018 First Quarter Financial Results Conference Call on April 30th
16/04/2018
WINTER SPRINGS, Fla., April 16, 2018 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD ) announced today that the Company will release its 2018 first quarter financial results before the market opens on Monday, [...]
Active Biotech's rights issue over subscribed
16/04/2018
2018-04-16 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OF THIS PRESS RELEASE WOULD [...]

Pages